Publicaciones en las que colabora con Luis Manzano Espinosa (19)

2024

  1. Prognosis of acute heart failure in patients followed up in nursing homes in Spain: Results from the RICA registry

    Medicina Clinica, Vol. 162, Núm. 4, pp. 157-162

  2. The two different profiles in heart failure with preserved ejection fraction and type 2 diabetes mellitus: ischemic and diabetic

    Current Medical Research and Opinion, Vol. 40, Núm. 3, pp. 359-366

2023

  1. Prognostic Impact of the UMIPIC Program in the Follow Up in Patients with Heart Failure and Cardiorenal Syndrome

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  2. Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice

    Future cardiology, Vol. 19, Núm. 6, pp. 343-351

2022

  1. Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC program

    Revista Clinica Espanola, Vol. 222, Núm. 6, pp. 339-347

  2. Influence of the degree of anaemia on the prognosis of older adults with heart failure (SPAN-HF study)

    Medicina Clinica, Vol. 158, Núm. 4, pp. 167-172

2021

  1. Consensus on basic conduct during the hospital admission of patients with acute heart failure

    Revista Clinica Espanola, Vol. 221, Núm. 5, pp. 283-296

  2. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

2019

  1. Hemoconcentration as a prognostic factor after hospital discharge in acute heart failure in the RICA registry

    Revista Clinica Espanola, Vol. 219, Núm. 1, pp. 1-9

  2. Prevalence and outcome of diuretic resistance in heart failure

    Internal and Emergency Medicine, Vol. 14, Núm. 4, pp. 529-537

  3. Prevalence and outcome of diuretic resistance in heart failure: reply

    Internal and Emergency Medicine

  4. The short-term prognostic value of C-reactive protein in elderly patients with acute heart failure

    Revista Clinica Espanola, Vol. 219, Núm. 1, pp. 10-17

2017

  1. Influence of renal dysfunction phenotype on mortality in decompensated heart failure with preserved and mid-range ejection fraction

    International Journal of Cardiology, Vol. 243, pp. 332-339

2016

  1. Precipitating factors of heart failure admission: Differences related to age and left ventricular ejection fraction

    International Journal of Cardiology, Vol. 219, pp. 150-155

  2. Rationale and Design of the “Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:” A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure

    Journal of Cardiac Failure, Vol. 22, Núm. 7, pp. 529-536

2015

  1. Actualización en las estrategias terapéuticas de la insuficiencia cardiaca crónica

    Medicina Clinica, Vol. 145, Núm. 12, pp. 545-550

  2. Prognostic value of glomerular filtration rate estimation equations in acute heart failure with preserved versus reduced ejection fraction

    International Journal of Clinical Practice, Vol. 69, Núm. 8, pp. 829-839

2005

  1. Different proinflammatory cytokine serum pattern in neonate patients undergoing open heart surgery. Relevance of IL-8

    Journal of Clinical Immunology, Vol. 25, Núm. 3, pp. 238-245

2002

  1. Newborn patients exhibit an unusual pattern of interleukin 10 and interferon γ serum levels in response to cardiac surgery

    Journal of Thoracic and Cardiovascular Surgery, Vol. 123, Núm. 3, pp. 451-458